Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome

October 17, 2011 updated by: Tioga Pharmaceuticals

A 12-Week, Randomized, Double-Blind, Dose-Ranging, Placebo-Controlled Study of Asimadoline in Subjects With Irritable Bowel Syndrome

The purpose of this study is to evaluate the safety and efficacy of different doses of asimadoline in the treatment of patients with irritable bowel syndrome.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

A randomized, dose-ranging, double-blind, placebo-controlled study designed to evaluate the efficacy and tolerability of three dose levels of asimadoline in subjects with IBS.

Study Type

Interventional

Enrollment (Actual)

596

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Huntsville, Alabama, United States, 35801
        • Medical Affiliated Research Center
    • Arizona
      • Pheonix, Arizona, United States, 85016
        • Lovelace Scientific Resources
      • Phoenix, Arizona, United States, 85029
        • Redpoint Research
      • Phoenix, Arizona, United States, 85016
        • Lovelace Scientific Resources
      • Scottsdale, Arizona, United States, 85259
        • Mayo Clinic Scottsdale - Division of Gastroenterology
      • Tucson, Arizona, United States, 85741
        • Genova Clinical Research
    • Arkansas
      • North Little Rock, Arkansas, United States, 72117
        • Arkansas Gastroenterology
    • California
      • Elk Grove, California, United States, 95758
        • Sutter Institute for Medical Research
      • Garden Grove, California, United States, 92840
        • Digestive & Liver Disease Specialists
      • Irvine, California, United States, 92618
        • Irvine Center for Clinical Research Inc.
      • Orange, California, United States, 92868
        • Community Clinical Trials
      • Sacramento, California, United States, 95816
        • Sutter Institute for Medical Research
      • Sacramento, California, United States, 95831
        • Nothern California Research
      • Westlake Village, California, United States, 91361
        • Westlake Medical Research
    • Colorado
      • Colorado Springs, Colorado, United States, 80909
        • Lynn Institute Of The Rockies
      • Longmont, Colorado, United States, 80501
        • Longmont Medical Research Network
      • Wheat Ridge, Colorado, United States, 80033
        • Western States Clinical Research Inc
    • Connecticut
      • Stratford, Connecticut, United States, 06615
        • Clinical Research Consultants, LLC
      • Waterbury, Connecticut, United States, 06708
        • Phoenix Internal Medicine Associates, Llc
    • Florida
      • Brooksville, Florida, United States, 34613
        • Meridian Research
      • Gainesville, Florida, United States, 32607
        • Florida Medical Research Institute
      • Hialeah, Florida, United States, 33010
        • Research Consultants Group
      • New Port Richey, Florida, United States, 34652
        • Suncoast Clinical Research
      • Orlando, Florida, United States, 32833
        • Universal Clinical Research & Technology
      • Ormond Beach, Florida, United States, 32174
        • Penninsula Research, Inc
      • Pinellas Park, Florida, United States, 33781
        • Radiant Research - St. Petersburg
      • Sarasota, Florida, United States, 34233
        • Lovelace Scientific Resources
      • St Petersburg, Florida, United States, 33709
        • Meridien Research
      • Tampa, Florida, United States, 33606
        • Meridien Research
    • Georgia
      • Marietta, Georgia, United States, 30067
        • Michael S. Levine, MD
      • Sandy Springs, Georgia, United States, 30318
        • Mount Vernon Clinical Research
      • Stockbridge, Georgia, United States, 30281
        • Clinical Research Atlanta
    • Illinois
      • Arlington Heights, Illinois, United States, 60005
        • Northwest Gastroenterologists S.C.
      • Chicago, Illinois, United States, 60622
        • Illinois Center for Clinical Research
      • Oak Forest, Illinois, United States, 60452
        • University Digestive Health Center
      • Riverside, Illinois, United States, 60546
        • BHS Digestive Disease Associates
      • Rockford, Illinois, United States, 61107
        • Rockford Gastroenterology Associates LTD
    • Indiana
      • Indianapolis, Indiana, United States, 46237
        • Indianapolis Gastroenterology Research Foundation
    • Iowa
      • Clive, Iowa, United States, 50325
        • Heartland Medical Research, Inc
    • Kansas
      • Wichita, Kansas, United States, 67207
        • Heartland Research Associates, LLC
      • Wichita, Kansas, United States, 67203
        • Professional Research Network of Kansas
    • Kentucky
      • Louisville, Kentucky, United States, 40202
        • University of Louisville GI Research
      • Madisonville, Kentucky, United States, 42431
        • Commonwealth Biomedical Research, LLC
    • Louisiana
      • Baton Rouge, Louisiana, United States, 70809
        • Digestive Health Center of Louisianna
    • Maryland
      • Annapolis, Maryland, United States, 21401
        • Digestive Disorders Associate
      • Baltimore, Maryland, United States, 21208
        • Woodholme Gastroenterology Associates, PA
      • Baltimore, Maryland, United States, 21229
        • Digestive Diseases Associates, PA
      • Chevy Chase, Maryland, United States, 20815
        • Chevy Chase Clinical Research MGG
      • Reisterstown, Maryland, United States, 21136
        • Clinical Associates Research
    • Massachusetts
      • Boston, Massachusetts, United States, 02215
        • Beth Israel Deaconess Medical Center
      • North Dartmouth, Massachusetts, United States, 02747
        • Northeast Medical Research Associates
    • Minnesota
      • Chaska, Minnesota, United States, 55318
        • Ridgeview Research
    • Mississippi
      • Jackson, Mississippi, United States, 39202
        • Gastrointestinal Associates, PA
      • Olive Branch, Mississippi, United States, 38654
        • Olive Branch Family Medical Center
    • Missouri
      • St. Louis, Missouri, United States, 63128
        • St. Louis Center for Clinical Research
    • Montana
      • Billings, Montana, United States, 59102
        • Montana Health Research Institute
    • Nebraska
      • Lincoln, Nebraska, United States, 68503
        • Gastroenterology Specialties, PC
      • Omaha, Nebraska, United States, 68198
        • University of Nebraska Medical Center
      • Omaha, Nebraska, United States, 68144
        • Dr. Meera Dewan, PC
    • New Mexico
      • Albuquerque, New Mexico, United States, 87106
        • New Mexico Clinical Research & Osteoporosis Center
    • New York
      • Great Neck, New York, United States, 11021
        • Long Island Clinical Research Associates
      • New York, New York, United States, 10021
        • Cornell Weill Medical College
    • North Carolina
      • Asheville, North Carolina, United States, 28801
        • Asheville Gastroenterology Associates, PA
      • Cary, North Carolina, United States, 27511
        • Cary Medical Research Associates
      • Chapel Hill, North Carolina, United States, 27599
        • UNC Chapel Hill
      • Charlotte, North Carolina, United States, 28209
        • Metrolina Medical Research
      • Charlotte, North Carolina, United States, 28207
        • Charlotte Gastroenterology and Hepatology
      • Fayetteville, North Carolina, United States, 28304
        • Cumberland Research Associates
      • Greensboro, North Carolina, United States, 27403
        • LeBauer Research Associates, PA
      • Hickory, North Carolina, United States, 28601
        • Unifour Medical Research Associates
      • Raleigh, North Carolina, United States, 27609
        • Triangle Medical Research Associates
      • Salisbury, North Carolina, United States, 28144
        • Crescent Medical Research
      • Wilmington, North Carolina, United States, 28401
        • Hanover Medical Specialists, PA
      • Wilmington, North Carolina, United States, 28412
        • New Hannover Medical Research
      • Winston-Salem, North Carolina, United States, 27103
        • Piedmont Medical Research Associates
    • Ohio
      • Akron, Ohio, United States, 44302
        • Akron Gastroenterology Assoc, Inc.
      • Cincinnati, Ohio, United States, 45249
        • Radiant Research
      • Cincinnati, Ohio, United States, 45220
        • Digestive Health Network
      • Columbus, Ohio, United States, 43212
        • Radiant Research
      • Kettering, Ohio, United States, 45429
        • Wells Institute for Health Awareness
      • Mogadore, Ohio, United States, 44260
        • Radiant Research - Akron
    • Oklahoma
      • Norman, Oklahoma, United States, 73701
        • Lion Research
      • Oklahoma City, Oklahoma, United States, 73104
        • Oklahoma Foundation for Digestive Research
      • Tulsa, Oklahoma, United States, 74104
        • Options Health Research, LLC
      • Tulsa, Oklahoma, United States, 74136
        • Castlerock Clinical Research Consultants, Llc
    • Oregon
      • Portland, Oregon, United States, 97210
        • NW Gastroenterology Clinic
      • Portland, Oregon, United States, 97225
        • West Hills Gastroenterology Associates, PC
    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15212
        • Allegheny Center for Digestive Health
      • Sayre, Pennsylvania, United States, 18840
        • Guthrie Clinical Research
    • Rhode Island
      • East Providence, Rhode Island, United States, 02917
        • Safe Harbor Clinical Research
    • South Carolina
      • Mt. Pleasant, South Carolina, United States, 29464
        • Coastal Carolina Research Center
      • Mt. Pleasant, South Carolina, United States, 29464
        • Palmetto Medical Research
      • Simpsonville, South Carolina, United States, 29681
        • Hillcrest Clinical Research
    • Tennessee
      • Chattanooga, Tennessee, United States, 37404
        • ClinSearch
      • Clarksville, Tennessee, United States, 37043
        • Alpha Clinical Research,LLC
      • Germantown, Tennessee, United States, 38138
        • Memphis Gastroenterology Group
      • Kingsport, Tennessee, United States, 37660
        • Gastroenterology Associates
      • Nashville, Tennessee, United States, 37205
        • Dial Research Associates, Inc
    • Texas
      • Austin, Texas, United States, 78752
        • Covance CRU-Austin
      • Conroe, Texas, United States, 77304
        • Sadler Clinic
      • El Paso, Texas, United States, 79905
        • Texas Tech University Health Sciences Center
      • Houston, Texas, United States, 77074
        • Clinical Trials Network
      • Houston, Texas, United States, 77004
        • Discovery Alliance
      • Houston, Texas, United States, 77036
        • Nationsmed Clinical Research
      • Lubbock, Texas, United States, 79430
        • Texas Tech University Health Sciences Center
      • San Antonio, Texas, United States, 78205
        • Sun Research Institute
    • Utah
      • Ogden, Utah, United States, 84405
        • Advanced Research Institute
      • Salt Lake City, Utah, United States, 84109
        • J. Lewis Research Inc., Foothills Family Clinic
    • Virginia
      • Charlottesville, Virginia, United States, 22911
        • Charlottesville Medical Research
      • Christiansburg, Virginia, United States, 24073
        • New River Valley Research Institute
      • Richmond, Virginia, United States, 23294
        • National Clinical Research inc
    • Wisconsin
      • Milwaukee, Wisconsin, United States, 53215
        • Wisconsin Center for Advanced Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 79 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Males and females aged 18-79
  • Must sign an ICF
  • Females of childbearing potential must have a negative pregnancy test at screening and must adhere to contraception throughout the trial
  • Must have been diagnosed with IBS as a result of having at least 6 months, not necessarily consecutive, in the preceding 12 months of recurrent symptoms of abdominal discomfort or pain associated with at least 2 of the following: 1)relieved with defecation; 2)onset associated with a change in stool frequency; 3)onset associated with a change in stool form
  • Must demonstrate a willingness to comply with daily telephone diary entry

Exclusion Criteria:

  • Any subject with evidence of a biochemical or structural abnormality of the digestive tract or other co-morbid illness that might impact the ability to interpret the safety and efficacy data
  • Pregnant or breastfeeding females
  • Refusal to discontinue prohibited concomitant medications
  • Use of an investigational drug or participation in an investigational study within 30 days of screening
  • Inability or unwillingness to use the touch-tone telephone data entry system

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: QUADRUPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
PLACEBO_COMPARATOR: Placebo
Placebo was provided in coated tablets identical in appearance to asimadoline tablets.
EXPERIMENTAL: Asimadoline 0.15 mg
Asimadoline was provided in coated tablets of three dosages (0.15 mg, 0.5 mg, and 1.0 mg). All asimadoline tablets used in this trial were synthesized from the same batch of drug substance (Batch EF418492). Asimadoline was administered orally, BID for 12 weeks
Other Names:
  • EMD 61753
  • EMR 63320
EXPERIMENTAL: Asimadoline 0.5 mg
Asimadoline was provided in coated tablets of three dosages (0.15 mg, 0.5 mg, and 1.0 mg). All asimadoline tablets used in this trial were synthesized from the same batch of drug substance (Batch EF418492). Asimadoline was administered orally, BID for 12 weeks
Other Names:
  • EMD 61753
  • EMR 63320
EXPERIMENTAL: Asimadoline 1.0 mg
Asimadoline was provided in coated tablets of three dosages (0.15 mg, 0.5 mg, and 1.0 mg). All asimadoline tablets used in this trial were synthesized from the same batch of drug substance (Batch EF418492). Asimadoline was administered orally, BID for 12 weeks
Other Names:
  • EMD 61753
  • EMR 63320

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Relief of IBS Pain - total months
Time Frame: 12 weeks
The primary efficacy endpoint of the study was the total number of months with adequate relief of IBS pain or discomfort.
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Relief of IBS Pain - percent of patients
Time Frame: 12 weeks
Proportion of subjects with adequate relief of IBS pain or discomfort
12 weeks
Relief of IBS Symptoms
Time Frame: 12 weeks
Adequate relief of IBS symptoms
12 weeks
Lower GI function - change from baseline
Time Frame: 12 weeks
Change from baseline in assessments of lower gastrointestinal (GI) function (i.e., stool frequency, stool consistency, urgency, bloating, and straining)
12 weeks
Abdominal Pain Score - change from baseline
Time Frame: 12 weeks
Change from baseline in abdominal pain score
12 weeks
Abdominal Discomfort Score - change from baseline
Time Frame: 12 weeks
Change from baseline in abdominal discomfort score
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Allen Mangel, MD, PhD, Tioga Pharmaceuticals

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2006

Primary Completion (ACTUAL)

November 1, 2007

Study Completion (ACTUAL)

December 1, 2007

Study Registration Dates

First Submitted

March 29, 2007

First Submitted That Met QC Criteria

March 29, 2007

First Posted (ESTIMATE)

April 2, 2007

Study Record Updates

Last Update Posted (ESTIMATE)

October 18, 2011

Last Update Submitted That Met QC Criteria

October 17, 2011

Last Verified

October 1, 2011

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Irritable Bowel Syndrome

Clinical Trials on Placebo

3
Subscribe